MedPath

Development of a Laboratory Test for the Detection of a Fluorescent-labeled Urease Inhibitor Marker Attached to Helicobacter Pylori

Not Applicable
Conditions
Helicobacter Pylori
Interventions
Diagnostic Test: Fluorescent-labeled Urease Inhibitor Marker to Detect Helicobacter Pylori
Registration Number
NCT04937426
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The aim of this study is to compare the usual rapid urease test (RUT) to a new florescent-labeled urease inhibitor marker to diagnose Helicobacter Pylori.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients undergoing gastroendoscopy with suspected Helicobacter Pylori
Exclusion Criteria
  • Patients with active bleeding
  • Patients treated with anti-coagulation medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fluorescent-labeled Urease Inhibitor Marker to Detect Helicobacter PyloriFluorescent-labeled Urease Inhibitor Marker to Detect Helicobacter PyloriDuring gastroscopy additional biopsies are taken in cases where infection with helicobacter pylori is suspected. It will then undergo laboratory analysis with fluorescent-labeled urease inhibitor marker. Results will be compared to standard analysis to determine efficacy.
Primary Outcome Measures
NameTimeMethod
Efficacy of a Fluorescent-labeled Urease Inhibitor Marker to Detect Helicobacter Pylori InfectionTwo years

Comparison of results of biopsies analyzed with a fluorescent-labeled urease inhibitor marker to detect Helicobacter Pylori infection and results will be compared to standard tests to detect Helicobacter Pylori

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

© Copyright 2025. All Rights Reserved by MedPath